This is an old revision of the document!


Johnson & Johnson

Subsidiaries

Janssen Pharmaceuticals is the pharmaceutical arm of J&J.

Acquisitions

Johnson & Johnson acquired Actelion in 2017 for $30 billion.1)

Payments from Johnson & Johnson

The following is a developing list of individuals and organizations that Johnson & Johnson has given money to related to the COVID-19 pandemic. People and groups included on this list are relevant due to positions of authority or influence in the crisis, and are of note in considering how J&J or Janssen may have manipulated the COVID-19 response through a payment network. Inclusion on this list does not constitute an accusation of wrongdoing without substantiating evidence.

1)
O’Donnell, C. (2021, November 12). How Johnson & Johnson became the sprawling healthcare giant it is today. Reuters. https://archive.ph/7BSfF
Back to top